Merit Medical Systems, Inc.
- Jurisdiction
United States - LEI
549300OYTY138SP2CE83 - ISIN
US5898891040 (MMSI )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€75.72 7.4% undervalued - Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
6
/ 7
Profile
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. Read full profile
Fundamentals
- Net revenue
€1.22B - Gross margin
47.9% - EBIT
€137.95M - EBIT margin
11.3% - Net income
€101.60M - Net margin
8.3%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ward Lynne N. | N/A |
|
|
|
|
| Ward Lynne N. | N/A |
|
|
|
|
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Buy |
| Ray Dalio |
|
|
|
Sell |
Earnings Calls
Latest earnings call: February 28, 2024 (Q4 2023)